112 related articles for article (PubMed ID: 4851044)
21. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
Kirch W; von Gizycki C
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
[No Abstract] [Full Text] [Related]
22. [Urapidil in primary arterial hypertension].
Román O; Sudy E; Gac JC; Valenzuela MA
Rev Med Chil; 1987 Jul; 115(7):648-54. PubMed ID: 3331026
[No Abstract] [Full Text] [Related]
23. Lisinopril and nifedipine in essential hypertension: a Norwegian multicenter study on efficacy, tolerability and quality of life in 828 patients.
Os I; Bratland B; Dahlöf B; Gisholt K; Syvertsen JO; Tretli S
J Hypertens Suppl; 1991 Dec; 9(6):S382-3. PubMed ID: 1668011
[No Abstract] [Full Text] [Related]
24. [Experiences with a new antihypertensive agent].
Stampfer E
Wien Klin Wochenschr; 1971 Jan; 83(4):66-9. PubMed ID: 4994618
[No Abstract] [Full Text] [Related]
25. [Treatment of arterial hypertension with the use of trandolapril for patients with metabolic syndrome].
Samsonova NG; Mikheeva OM; Nilova TV
Eksp Klin Gastroenterol; 2007; (1):51-4. PubMed ID: 17547114
[No Abstract] [Full Text] [Related]
26. Comparative evaluation of the antihypertensive activities of losartan and HM70186 during liver dysfunction.
Lee S
Arch Pharm Res; 2009 Jul; 32(7):965-6. PubMed ID: 19641875
[No Abstract] [Full Text] [Related]
27. [Longterm treatment with a new antihypertensive agent].
Wolkerstorfer H
Wien Med Wochenschr; 1969 Jun; 119(25):502-4. PubMed ID: 5802413
[No Abstract] [Full Text] [Related]
28. Lofexidine, a new, antihypertensive imidazoline derivative. Clinical profile of action with single-drug treatment and in combination with hydrochlorothiazide.
Aigner A; Schmidt U
Arzneimittelforschung; 1982; 32(8a):976-83. PubMed ID: 6890373
[No Abstract] [Full Text] [Related]
29. [Behavior of hemodynamic values of patients with hypertension during dichlorphenylamino-imidazoline therapy].
Pozenel H
Wien Klin Wochenschr; 1969 Mar; 81(11):187-92. PubMed ID: 4935483
[No Abstract] [Full Text] [Related]
30. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
31. [Open study on the effect and side effects of indoramin, used at the 2d and 3d therapeutic step in essential hypertension].
Hitzenberger G; Korn A
Wien Med Wochenschr; 1985 Sep; 135(17):425-30. PubMed ID: 4060742
[TBL] [Abstract][Full Text] [Related]
32. [Ambulatory registration of arterial pressure during treatment with perindopril. Effects on systolic pressure and hemodynamic implications].
Santoni JP; Asmar RG; Bizot-Espiard JG; Safar M
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():51-6. PubMed ID: 2505713
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and tolerability of trandolapril in mild to moderate hypertension--a double blind comparative clinical trial with enalapril in Indian population.
Shankar PK; Vidyasagar S; Adiga S; Naidu MU; Usha Rani P; Rao D; Bairy KL; Nair S; Jayaprakash B; Shashikiran U; Mukhyapranaprabhu
Indian J Physiol Pharmacol; 2006; 50(4):421-6. PubMed ID: 17402274
[TBL] [Abstract][Full Text] [Related]
34. Pharmacologic studies of indoramin in man.
Royds RB; Coltart DJ; Lockhart JD
Clin Pharmacol Ther; 1972; 13(3):380-92. PubMed ID: 4402080
[No Abstract] [Full Text] [Related]
35. Prevention of exercise-induced asthma by indoramin.
Bianco S; Griffin JP; Kamburoff PL; Prime FJ
Br Med J; 1974 Oct; 4(5935):18-20. PubMed ID: 4154121
[TBL] [Abstract][Full Text] [Related]
36. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.
Gilmore E; Weil J; Chidsey C
N Engl J Med; 1970 Mar; 282(10):521-7. PubMed ID: 4391708
[No Abstract] [Full Text] [Related]
37. Indoramin as an antihypertensive agent in the treatment of essential hypertension. A multicentre trial.
Bednarek MR; Schoeman HS
S Afr Med J; 1983 Mar; 63(11):398-400. PubMed ID: 6338603
[TBL] [Abstract][Full Text] [Related]
38. [Clinical examination of a combined antihypersensitive agent containing hydrogenated ergot alkaloid].
Wanner J
Schweiz Med Wochenschr; 1968 Aug; 98(32):1196-201. PubMed ID: 4974016
[No Abstract] [Full Text] [Related]
39. [24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study].
Widimský J; Fedelesová V; Uhlír O
Vnitr Lek; 1995 Jul; 41(7):441-4. PubMed ID: 7571476
[TBL] [Abstract][Full Text] [Related]
40. [The use of perindopril (prestarium) in arterial hypertension].
Filatova NP
Ter Arkh; 1995; 67(9):81-3. PubMed ID: 7495054
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
